PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Independence Market is a revolutionary new way to shop, designed for busy mums whose time and attention is precious yet have high standards for their families.
days to go:
Expired
investment:
£158,598
Cook My Grub (CMG) is an online food delivery marketplace that offers fresh and authentic home-cooked food using Artificial Intelligence (AI) and Machine Learning (ML). CMG allows customers to choose their food from options such as vegetarianism, veganism, halal, and gluten-free. Customers can use CMG's app to order food on the same day or pre-order several days or even weeks in advance. CMG points out that it sets up 'Virtual Restaurants' for home-chefs giving them the flexibility to decide when, what, and how much they aim to cook. It aims to be a contender in the £10+ billion UK restaurant delivery market. CMG argues that it has served 1300+ meals across Maidenhead, Windsor, and Slough. It has planned future expansion across London, Reading, Swindon, and Home Counties. The company has featured in publications like BBC Berkshire Radio, Public Sector Catering, Business Cloud, and TechFound. It will use the investment to increase marketing, scale-up operations, and grow its technology teams.
days to go:
Expired
investment:
£685,544
Brands reunited are looking to disrupt the modern craft beer market. Their sales are over £400k and are growing 100% year on year. They have two brands that are already in Watneys and Home Ales. The funding will be spent on building their brand and the team.
days to go:
Expired
investment:
£255,000
Moody is a health-tracking application that connects users with customised health, food and fitness advice based on their moods, symptoms and cycles. It endeavours to become a sustainable force for good in women's health. The company argues that women control >80% of household health spend and are 80% more likely than men to use a digital health app. It aims to harness these trends and capitalise on the global remote health care market that is forecast to hit £40 billion by 2025. 'The Moody Month' app featured in publications like Vogue, Grazia and The Guardian. It has witnessed over 136,000 downloads since its Version 1 release in 2019. The app has compiled over 5 million moods to date. The company will use the investment to scale its business globally and reach 1 million subscribers within a four-year time frame.
days to go:
Expired
investment:
£142,026
The London Jam Factory is a jam manufacturer that has created over 90 flavours. They already deliver online in the UK and currently have their products in a number of coffee shops and bakeries. With the funds invested, The London Jam Company aim to increase production facilities.
days to go:
Expired
investment:
£127,760
We are a property Market Place matching Buyers and Sellers, Landlords and Tenants without the use of estate agents. The online portal will dramatically reduce the fees that sellers and landlords pay agents to find buyers and tenants for their properties
days to go:
Expired
investment:
Withheld
